Nemaura Medical Inc reports results for the quarter ended in March - Earnings Summary

Nemaura Medical

13/07/2023 22:18

* Nemaura Medical Inc  NMRD.OQ  reported a quarterly
adjusted loss
of 18 cents​​ per share for the quarter ended in March. The mean
expectation of three analysts for the quarter was for a loss
of 16 cents per share.
    * Reported revenue was zero​; analysts expected $200.00
thousand. 
    * Nemaura Medical Inc's reported EPS for the quarter was a
loss
of 18 cents​.
    * The mean earnings estimate of analysts was unchanged in
the last
three months.​ 
    * In the last 30 days, there have been no earnings estimate
revisions by analysts covering the company. 
    * Nemaura Medical Inc shares had risen by 7.0% this
quarter and
lost 42.3% so far this year.
    * The company reported a quarterly loss of $4.68 million.
    * Wall Street's median 12-month price target for Nemaura
Medical
Inc is $7.00 
    * The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 3 "strong buy" or "buy," no
"hold" and no "sell" or "strong sell." 

This summary was machine generated from LSEG Refinitiv data July
13 at 09:18 p.m. UTC. ​All figures in US dollars unless
otherwise stated. QUARTER ENDING    ESTIMATE       ACTUAL         BEAT, MET,
                                                 MISSED
 Mar. 31 2023      -0.16          -0.18          Missed
 Dec. 31 2022      -0.18          -0.07          Beat
 Sep. 30 2022      -0.17          -0.17          Met
 Jun. 30 2022      -0.17          -0.17          Met